Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, With Open Label Extension, in Patients With Treatment-Resistant Depression

NCT05870540 is registered in ClinicalTrials.gov with Beckley Psytech Limited as lead sponsor.

NCT NCT05870540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, With Open Label Extension, in Patients With Treatment-Resistant Depression
Lead sponsor
Beckley Psytech Limited
Phase
Phase 2
Overall status
Completed
Start date
September 14, 2023
Completion date
July 3, 2025
Enrollment
196 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression